Dabur Pharmaceutical Ltd - Company Profile

Q: Who are the current directors of Dabur Pharmaceutical Ltd?

The current directors of Dabur Pharmaceutical Ltd are Gaurav Chamaria, Ram Prakash Sharma, Akhil Mahajan.

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1985.

1985 New Delhi, Delhi, India Active

Last Updated: January 06, 2026

About Dabur Pharmaceutical Ltd

Dabur Pharmaceutical Ltd, a active public limited company, was established on 25 June 1985 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24231DL1985PLC021308. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.10 Cr and a paid-up capital of ₹1.96 Cr.

Formerly known as Key Pharmaceuticals Pvt Ltd, Key Pharmaceuticals Ltd. It upholds a compliant status. Its leadership includes Gaurav Chamaria (Director), Ram Prakash Sharma (Additional Director), Akhil Mahajan (Director). Past directors included Aditya Chand Burman, Shailendra Tandon, Anurag Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, 110002.

Company Details

CIN/LLPIN
U24231DL1985PLC021308
Registration Number
021308
Incorporation Date
25 June 1985
Authorized Capital
₹2.10 Cr
Paid-Up Capital
₹1.96 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.10 Cr as on 06-01-2026
Paid Up Capital ₹ 1.96 Cr as on 06-01-2026
Company Age 40 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** % (FY 2023)
Profit Growth **** 3.60% (FY 2023)
Ebitda **** 31.71% (FY 2023)
Net Worth -11.03% (FY 2023)
Total Assets -7.64% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Dabur Pharmaceutical Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Dabur Pharmaceutical Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Gaurav Chamaria	Director	15 May 2025	Current
Ram Prakash Sharma	Additional Director	10 Nov 2025	Current
Akhil Mahajan	Director	23 Jan 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	05 Mar 2012	Past
Pramod Abcsdd	Additional Director	28 Sep 2012	Past
Pramod Abcsdd	Additional Director	30 Sep 2015	Past
Pramod Abcsdd	Director	09 Aug 2019	Past
Pramod Abcsdd	Additional Director	29 Sep 2025	Past
Pramod Abcsdd	Director	22 Jan 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dabur Pharmaceutical.

Dabur Pharmaceutical Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.03%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

-7.64%

*******

Profit or Loss

*******

3.60%

*******

Net Worth

*******

-11.03%

*******

EBITDA

*******

31.71%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dabur Pharmaceutical?

In 2023, Dabur Pharmaceutical had a promoter holding of 97.11% and a public holding of 2.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dabur Pharmaceutical?

Unlock and access historical data on people associated with Dabur Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Dabur Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dabur Pharmaceutical's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dabur Pharmaceutical

Recent Activity within the Organization

Director Appointment

Ram Prakash Sharma was appointed as a Additional Director was appointed as a Additional Director on 10 Nov 2025 & has been associated with this company since 6 months 8 days . was recorded as a recent event.
10 Nov 2025
Director Appointment

Progress on Gaurav Chamaria was appointed as a Director was appointed as a Director on 15 May 2025 & has been associated with this company since 1 year 3 days . was documented.
15 May 2025
Annual General Meeting

Progress on Dabur Pharmaceutical Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Balance Sheet

The activity Dabur Pharmaceutical Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
31 Mar 2024
Director Appointment

The activity Akhil Mahajan was appointed as a Director was appointed as a Director on 23 Jan 2024 & has been associated with this company since 2 years 3 months . was completed.
23 Jan 2024
Company Incorporation

Dabur Pharmaceutical Ltd was registered on 25 Jun 1985 with Roc Delhi & aged 40 years 10 months as per MCA records. was recorded as a recent event.
25 Jun 1985

Explore recent activity and updates - View Recent Activity